Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma

Clinical trial NCT02959879 · COMPLETED

Trial details

NCT number: NCT02959879
Sponsor: University Hospital, Rouen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Pancreatic Duct Adenocarcinoma

Start date: 2017-03-01
Primary completion: 2023-08-08
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.